|
NAPB expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.831500E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.480130E-02 |
| Normal-vs-Stage2 |
9.721000E-01 |
| Normal-vs-Stage3 |
4.673900E-02 |
| Normal-vs-Stage4 |
1.317610E-01 |
| Stage1-vs-Stage2 |
2.153400E-01 |
| Stage1-vs-Stage3 |
8.190000E-01 |
| Stage1-vs-Stage4 |
5.169600E-01 |
| Stage2-vs-Stage3 |
2.715200E-01 |
| Stage2-vs-Stage4 |
3.894600E-01 |
| Stage3-vs-Stage4 |
6.991400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.525800E-02 |
| Normal-vs-AfricanAmerican |
2.328800E-01 |
| Normal-vs-Asian |
8.113400E-01 |
| Caucasian-vs-AfricanAmerican |
5.531800E-01 |
| Caucasian-vs-Asian |
6.348000E-01 |
| AfricanAmerican-vs-Asian |
7.383600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.150000E-02 |
| Normal-vs-Female |
6.301700E-02 |
| Male-vs-Female |
7.699200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.563400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.902300E-02 |
| Normal-vs-Age(61-80Yrs) |
3.966500E-02 |
| Normal-vs-Age(81-100Yrs) |
4.249400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.849800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.591000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.401000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.581800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.026600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.697200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.585400E-01 |
| Normal-vs-Grade 2 |
9.394200E-02 |
| Normal-vs-Grade 3 |
1.216220E-02 |
| Normal-vs-Grade 4 |
3.675600E-01 |
| Grade 1-vs-Grade 2 |
4.168600E-01 |
| Grade 1-vs-Grade 3 |
3.396200E-01 |
| Grade 1-vs-Grade 4 |
6.640800E-01 |
| Grade 2-vs-Grade 3 |
3.925600E-01 |
| Grade 2-vs-Grade 4 |
7.998200E-01 |
| Grade 3-vs-Grade 4 |
4.915200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.236630E-01 |
| Normal-vs-ccB subtype |
4.884000E-02 |
| ccA subtype-vs-ccB subtype |
5.673600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.369000E-01 |
| Normal-vs-N1 |
7.605800E-01 |
| N0-vs-N1 |
6.387200E-01 |
|
|
